Government Announces Pricing & Reimbursement Overhaul

Greece's pricing and reimbursement environment is set for a period of transformation, which will see price freezes or reductions for originator drugs, the introduction of referencing for generic medicines and tighter conditions for reimbursement coverage. In mid-November 2009 Greece's new health minister Mariliza Xenogiannakopoulou presented the recently-elected government's overhaul to the system, which aims to save EUR1.5bn (US$2.2bn) in 2010. BMI commends the new government's strong action in seeking to rein in excessive spending; however, we note that sections of the industry will suffer considerably over the medium term.

To read the full article, please choose one of the following options: